Skip to main content

Episode 36: Effects of Antiplatelet Therapy After Stroke Due to Intracerebral Hemorrhage (RESTART)

Loading audio, please wait...


On this episode, Dr. Jim Siegler is joined by Dr. Rustam Al-Shahi Salman to discuss his recent article, "Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial."

The NCS Podcast is the official podcast of the Neurocritical Care Society. Our senior producer is Bonnie Rossow. Our host is Fawaz Almufti, and our production staff includes Ramani Balu, Michael Brogan, Joshua Levine, Sarah Stern-Nezer, Benjamin Miller, Starane Shepherd, and Chris Zammit. Our administrative staff includes Bonnie Rossow and Angel Gindele. Music by Mohan Kottapally.


  • Rustam Al-Shahi Salman

    Dr. Rustam Al-Shahi Salman leads the Research to Understand Stroke due to Haemorrhage (RUSH) programme, which is dedicated to improving the outcome for adults who have diseases that may cause, or have caused, intracranial hemorrhage. The fundamental study designs of clinical epidemiology - such as randomised controlled trials, community- or population-based cohort and case-control studies, brain banking, and meta-analysis - are the foundation of my focus on the frequency, prognosis, treatment, and pathophysiology of intracranial haemorrhage. He also cares for people with these conditions, audits their care, and helps undergraduate and postgraduate students to develop and answer research questions within the RUSH programme.